Drug Profile
Research programme: diabetes and obesity therapeutics - Hanmi Pharmaceutical
Alternative Names: DGAT - Hanmi; DGAT1 inhibitor - Hanmi; GPR119 agonist - Hanmi; HM 47000Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class
- Mechanism of Action Diacylglycerol O acyltransferase inhibitors; GPR119 protein agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus; Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Diabetes-mellitus in South Korea
- 16 Jul 2016 No recent reports of development identified for research development in Obesity in South Korea